Full-Time

Scientist – Immunology Quality Control Laboratory

Confirmed live in the last 24 hours

Zoetis

Zoetis

5,001-10,000 employees

Food & Agriculture
Healthcare

Senior

Lincoln, NE, USA

Category
Veterinary Professionals
Medical, Clinical & Veterinary
Required Skills
Data Analysis

You match the following Zoetis's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • B.S. in Immunology, Biochemistry, Molecular Biology, or a related field
  • Minimum of 5 years of experience in an immunology laboratory, preferably in the pharmaceutical or biotechnology industry
  • Strong leadership and project management skills
  • Excellent analytical, problem-solving, and communication skills
  • Ability to work independently and as part of a collaborative team
  • Familiarity with regulatory requirements and quality control standards
Responsibilities
  • Lead the transfer and validation of immunological assays
  • Oversee daily laboratory operations, ensuring compliance with regulatory standards and company policies
  • Mentor and supervise Quality Analysts
  • Collaborate with cross-functional teams to support product development and quality control
  • Analyze and interpret complex data, providing actionable insights and recommendations
  • Prepare and review technical reports, protocols, and regulatory submissions
  • Stay current with advancements in immunology and related fields, integrating new knowledge into laboratory practices
Desired Qualifications
  • M.S. or equivalent in Biological Sciences or a closely related field with 1-3 years of experience
  • Experience performing and troubleshooting ELISA and Immunochemical Assays
  • General understanding of protein chemistry and antibody-antigen interactions
  • Knowledge of USDA and EP requirements associated with Quality Control assay development and testing
  • Proven project and resource management experience

Company Size

5,001-10,000

Company Stage

IPO

Total Funding

$14.9M

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Simplify Jobs

Simplify's Take

What believers are saying

  • Zoetis benefits from the growing veterinary telehealth market and increased pet ownership.
  • The rise of pet insurance boosts demand for Zoetis' advanced veterinary services.
  • Zoetis' focus on sustainable practices aligns with industry trends and consumer preferences.

What critics are saying

  • Emerging biotech firms in animal health could threaten Zoetis' market share.
  • Alternative protein sources may reduce demand for traditional animal health products.
  • Animal rights backlash against testing practices could harm Zoetis' public image.

What makes Zoetis unique

  • Zoetis leads the animal health industry with innovative products like Vetscan OptiCell.
  • The company has a strong history, originating from a Pfizer spinoff in 2013.
  • Zoetis collaborates with institutions like Colorado State University for sustainable animal production.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Company News

MarketBeat
Jan 17th, 2025
Miracle Mile Advisors LLC Makes New $272,000 Investment in Zoetis Inc. (NYSE:ZTS)

Miracle Mile Advisors LLC makes new $272,000 investment in Zoetis Inc. (NYSE:ZTS).

TipRanks
Jan 13th, 2025
Zoetis Highlights Growth at J.P. Morgan Conference

Zoetis announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, showcasing its exemplary 2024 performance and strategic growth initiatives.

Stock Titan
Jan 7th, 2025
Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?

BetterInvesting Magazine has selected Zoetis (NYSE: ZTS) as its 'Stock to Study' for the March 2025 issue, suggesting the stock warrants further investigation by investors.

Grand View Research
Jan 1st, 2025
Animal Health Market Size To Reach $112.33 Billion By 2030

For instance, in January 2021, Zoetis launched the Poulvac Procerta HVT-IBD vaccine for poultry to protect against Infectious Bursal Disease (IBD).

Governance Intelligence
Dec 31st, 2024
GeneDx appoints former Zoetis general counsel as legal chief

Chen has joined GeneDx from Zoetis, where she was general counsel and corporate secretary for almost 12 years, a role she took on following the company's spinoff from Pfizer in 2013.